CVS Health Corp (CVS) Position Lessened by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky trimmed its position in shares of CVS Health Corp (NYSE:CVS) by 3.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 245,903 shares of the pharmacy operator’s stock after selling 9,500 shares during the quarter. Teachers Retirement System of The State of Kentucky’s holdings in CVS Health were worth $19,786,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Pathstone Family Office LLC lifted its holdings in shares of CVS Health by 341.0% during the second quarter. Pathstone Family Office LLC now owns 1,270 shares of the pharmacy operator’s stock valued at $2,353,000 after purchasing an additional 982 shares during the last quarter. TB Alternative Assets Ltd. purchased a new position in CVS Health in the 2nd quarter worth approximately $121,000. Gemmer Asset Management LLC raised its holdings in CVS Health by 15.3% in the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after acquiring an additional 200 shares during the last quarter. Captrust Financial Advisors purchased a new position in CVS Health in the 2nd quarter worth approximately $155,000. Finally, SRS Capital Advisors Inc. raised its holdings in CVS Health by 48.2% in the 1st quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after acquiring an additional 734 shares during the last quarter. 82.24% of the stock is currently owned by institutional investors and hedge funds.

In other CVS Health news, EVP Thomas M. Moriarty sold 90,267 shares of the stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the completion of the transaction, the executive vice president now owns 70,102 shares of the company’s stock, valued at approximately $5,580,820.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO David M. Denton sold 237,078 shares of the stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $79.65, for a total transaction of $18,883,262.70. Following the transaction, the chief financial officer now directly owns 141,096 shares of the company’s stock, valued at approximately $11,238,296.40. The disclosure for this sale can be found here. Insiders sold a total of 714,125 shares of company stock valued at $58,119,381 in the last ninety days. 0.61% of the stock is currently owned by insiders.

A number of brokerages recently weighed in on CVS. Royal Bank Of Canada began coverage on shares of CVS Health in a report on Tuesday, September 19th. They issued an “outperform” rating and a $95.00 price objective for the company. Jefferies Group boosted their target price on shares of CVS Health from $82.00 to $86.00 and gave the company a “hold” rating in a research note on Friday, September 15th. Needham & Company LLC reiterated a “hold” rating on shares of CVS Health in a research note on Sunday, September 10th. Wolfe Research lowered shares of CVS Health from an “outperform” rating to a “market perform” rating and decreased their target price for the company from $89.00 to $82.00 in a research note on Monday, August 14th. Finally, Robert W. Baird reiterated an “outperform” rating and set a $90.00 target price on shares of CVS Health in a research note on Monday, August 14th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have assigned a buy rating to the company. CVS Health has a consensus rating of “Buy” and a consensus price target of $86.35.

Shares of CVS Health Corp (CVS) traded up $0.37 during trading on Thursday, reaching $71.38. 12,371,700 shares of the company traded hands, compared to its average volume of 6,904,070. The company has a market cap of $71,932.56, a P/E ratio of 12.44, a P/E/G ratio of 1.22 and a beta of 0.89. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.05 and a quick ratio of 0.55. CVS Health Corp has a one year low of $66.45 and a one year high of $84.72.

CVS Health (NYSE:CVS) last issued its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.01. The company had revenue of $46.18 billion during the quarter, compared to the consensus estimate of $46.17 billion. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. CVS Health’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.64 EPS. analysts anticipate that CVS Health Corp will post 5.9 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This report was published by Community Financial News and is owned by of Community Financial News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.com-unik.info/2017/12/07/cvs-health-corp-cvs-position-lessened-by-teachers-retirement-system-of-the-state-of-kentucky.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

What are top analysts saying about CVS Health Corp? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CVS Health Corp and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit